Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-05-30
2006-05-30
Housel, James (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S234100, C424S184100, C530S350000
Reexamination Certificate
active
07052697
ABSTRACT:
The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated byLawsonia intracellularisor similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived fromLawsonia intracellulariswhich encodes an immunogenic OmpH peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity againstLawsonia intracellularisand related pathogens in animal hosts. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detectingLawsonia intracellularisor similar or otherwise related microorganisms.
REFERENCES:
patent: 5885823 (1999-03-01), Knittel et al.
patent: WO 97/20050 (1997-06-01), None
patent: PCT WO 96/39629 (1996-12-01), None
patent: PCT WO 97/20040 (1997-06-01), None
McCluskey et al., Infection and Immunity, vol. 70 No 6, pp. 2899-2907 (Jun. 2002).
Bowie et al., Science, Vlume 247 No 4948 (Mar. 1990).
Riffkin et al., Gene, colume 167, pp. 279-283 (1995).
Pinnila et al., Molecular Immunology, Colume 30 No 6, pp. 577-585 (1993).
Guedes et al., Veterinary Microbiology, vol. 91 No 2-3, pp. 135-145 (Feb. 2003).
Guedes et al., Veterinary Microbiology, vol. 93 No 2, pp. 159-166 (May 2003).
Kroll et al., American Journal of Veterinary Research, vol. 65, No 5, pp. 559-565 (May 2004).
Basaraba, R.J., Byerly, A.N. Stewart, G.C., Mosier, D.A. Fenwick, B.W., Chengappa, M.M., and Laegreid, W.W., “Actin enhances the haemolytic activity ofEscherichia coli,”, Microbiology, 144:1845-1852 (1998).
Nollau, P., Moser, C. Wagener,BioTechniques, 20:784-788 (1996).
Boye et al., Specific Detection ofLawsonia intracellularisin Porcine Proliferation Enteropathy Inferred From Fluorecent rRNA In Situ Hybridization, Vet Pathol 35:153-156 (1998).
Altuvia, Y. et al.,J. Mol. Biol., 249:244-250 (1995).
Amann and Brosius,Gene, 40:183 (1985).
Anderson, B.J. et al.,Journal of Bacteriology, 160:748-754 (1984).
Barker, I.K. et al., “Pathology of Domestic Animals,” 3rdEdition, vol. 2, 1-37, eds., K.V.F. Jubb, P.C. Kennedy, and N. Palmer (Academic Press: Orlando) (1985).
DeGroot, A.S. et al.,Vaccines, 96, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1995).
Devereux, J. et al.,Nucl. Acids Res., 12:387-395 (1984).
Elwell, M.R. et al.,Veterinary Pathology, 18:136-139 (1981).
Fox, J.G. et al.,Veterinary Pathology, 26:515-517 (1989).
Gebhart, C.J. et al.,American Journal of Veterinary Research.44:361-367 (1983).
Gish, W. et al.,Nature Genetics, 3:266-272 (1993).
Goodman et al.,Biopolymers, 26:525-532 (1987).
Huse et al,Science, 246:1275-1281 (1989).
Jones et al,Am. J. Vet. Res., 58:1125-1131 (1997).
Jonsson, L. et al,Acta Veterinaria Scandinavica, 17:223-232 (1976).
Kohler and Milstein,Nature, 256:495-499 (1975).
Kozbor et al.,Immunol. Today. 4:72 (1983).
Lawson et al.,Journal of Clinical Microbiology, 31:1136-1142 (1993).
Love, R.J. et al.,Veterinary Record, 100:473 (1977).
Margalit, H. et al.,J. Immunol., 138:2213-2229 (1987).
Mason, R.W. et al.,Australian Veterinary Journal(1998).
McOrist, S., et al.,The Veterinary Record, 121:421-422 (1987).
McOrist, S. et al.,Infection and Immunity, 61:4286-4292 (1993).
McOrist, S. et al.,International Journal of Systematic Bacteriology, 45:820-925 (1995).
Meister et al.,Vaccine, 13:581-591 (1995).
Mierke et al.,Int. J. Peptide Protein Research, 35:35-45 (1990).
Mohapatra, S.S. et al.,Allergy, 50:37-44 (1995).
Needleman and Wunsch,J. Mol. Biol., 48:443-453 (1970).
O'Neil, I., P.A.Veterinary Record, 87:742-747 (1970).
Parker, K.C. et al.,J. Immunol., 152:163-175 (1994).
Portoghese et al.,J. Med. Chem., 33:1714-1720 (1990).
Reinhartz, A. et al.,Gene, 136:221-226 (1993).
Rowland, A.C. et al.Veterinary Record, 97:178-180 (1976).
Schodeb, T.R. et al.,Veterinary Pathology, 27:73-80 (1990).
Shimatake and Rosenberg,Nature, 292:128 (1981).
Stills, H.F.,Infection and immunology, 59:3227-3236 (1991).
Straw, B.E.,Journal of American Veterinary Medical Association, 197:355-357 (1990).
Studier and Moffat,J. Mol. Biol., 189:113 (1986).
Thompson, J.D. et al.,Nucl. Acids Res., 22:4673-4680 (1994).
Vajda, S. et al.,Biopolymers, 29:1755-1772 (1990).
Van Regenmortel, “Molecular dissection of protein antigens,”Structure of antigens, 1-27 (1992).
Hasse Detlef
Panaccio Michael
Sinistaj Meri
Agriculture Victoria Services PTY LTD
Housel James
Kohn Kenneth I.
Kohn & Associates PLLC
Lucas Zachariah
LandOfFree
Lawsonia derived gene and related OmpH polypeptides,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lawsonia derived gene and related OmpH polypeptides,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lawsonia derived gene and related OmpH polypeptides,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649398